Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Halozyme's PEGPH20 Study S1313 Clinical Hold Lifted by FDA
Halozyme's PEGPH20 Study S1313 Clinical Hold Lifted by FDA
Halozyme's PEGPH20 Study S1313 Clinical Hold Lifted by FDA
Submitted by
admin
on September 20, 2014 - 8:52am
Source:
Yahoo/Zacks
News Tags:
Halozyme
PEGPH20
pancreatic cancer
metastatic pancreatic cancer
Headline:
Halozyme's PEGPH20 Study S1313 Clinical Hold Lifted by FDA
Do Not Allow Advertisers to Use My Personal information
